EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Mucins in Cancer and Cancer Progression: A Comprehensive Review

Clare Chen, Ameena Patel, Lusine Demirkhanyan iD, Christopher S Gondi

Current Issues in Molecular Biology · 29.05.2025 · 47 (6) · 406

DOI: 10.3390/cimb47060406 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 29.05.2025. Verfasst von Clare Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Illinois College of Medicine Peoria, Peoria, IL 61605, USA. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 290 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Illinois Collage of Medicine Peoria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucin, a heavily glycosylated glycoprotein, serves an important function in forming protective and immune defense barriers against the exterior environment on epithelial surfaces. While secreted-type mucins are involved in mucous production, transmembrane mucins, which contain O-glycosylated tandem repeats, play a pivotal role in cellular signaling, especially in immune modulation and mediating inflammatory response. However, dysregulation in mucin expressions, such as MUC1, MUC2, MUC4, MUC5AC, and MUC16, have been observed in many cancer cells. More specifically, alterations in the expression and glycosylation of MUC1 have been associated with the upregulation of pathways involving the cell proliferation, angiogenesis, migration, and invasion of cancer cells. With mucin’s extensive involvement in cancer biology, several mucin biomarkers, such as CA125, CA19-9, and CEA, have been utilized as diagnostic and prognostic monitoring biomarkers in ovarian, pancreatic, and colon cancer. Vaccines and antibody therapy against abnormal mucin glycosylation have also been investigated for potential therapy for mucin-related cancers that are resistant to traditional chemotherapy agents. Despite the lack of specificity in mucin biomarkers and challenges in efficient drug delivery systems, the current advancement in mucin-targeted immunotherapy highlighted the pivotal potential in developing therapeutic targets to improve cancer prognosis.

Schlagwörter

Stichwörter der Autor:innen

O-glycosylationantibody therapeuticsmetastatic cascademucin

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Illinois College of Medicine Peoria, Peoria, IL 61605, USA.
  • Department of Surgery, University of Illinois College of Medicine Peoria, Peoria, IL 61605, USA.
  • Departments of Health Science Education and Pathology, University of Illinois College of Medicine Peoria, Peoria, IL 61605, USA.
  • Health Care Engineering Systems Center, The Grainger College of Engineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.

ORCID-Profile: Lusine Demirkhanyan

Förderung

  • University of Illinois Collage of Medicine Peoria

Zitieren

APA

Chen, C., Patel, A., Demirkhanyan, L., & Gondi, C. S. (2025). The Role of Mucins in Cancer and Cancer Progression: A Comprehensive Review. Current Issues in Molecular Biology, 47(6), 406. https://doi.org/10.3390/cimb47060406

Vancouver

Chen C, Patel A, Demirkhanyan L, Gondi CS. The Role of Mucins in Cancer and Cancer Progression: A Comprehensive Review. Current Issues in Molecular Biology. 2025;47(6):406. doi:10.3390/cimb47060406

BibTeX
@article{Chen2025,
  author = {Chen, Clare and Patel, Ameena and Demirkhanyan, Lusine and Gondi, Christopher S},
  title = {The Role of Mucins in Cancer and Cancer Progression: A Comprehensive Review},
  journal = {Current Issues in Molecular Biology},
  year = {2025},
  volume = {47},
  number = {6},
  pages = {406},
  doi = {10.3390/cimb47060406}
}
Kostenlos starten →